|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
| 2 | Fifty-two-week treatment with diet and exercise plus transdermal testoster- one reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone显示文摘 | Heufelder AE Saad F Bunck MC | 2009 | J Androl2009，30，6： | 1 |
| 3 | Exenatide affectscirculating cardiovascular risk biomarkers independently ofchanges in body composition显示文摘 | Bunck MC Diamant M Eliasson | 2010 | Diabetes Care2010，33，8： | 1 |
| 4 | One-year treatment with exenatide improves beta-cell function, compared with insulin glagine , in metformin-treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 5 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Cornér A | | 0，，： | 1 |
| 6 | Incretin mimetics as anovel therapeutic option for hepatic steatosis显示文摘 | Tushuizen ME Bunck MC Pouwels PJ | 2006 | Liver International:Official Journal of the International Association for the Study of theLiver2006，26，8： | 1 |
| 7 | One- year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin- treated type 2 diabetic patients : a randomized, controlled trial显示文摘 | BUNCK MC DIAMANT M CORNER A | 2009 | Diabetes Care2009，32，5： | 1 |
| 8 | Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes显示文摘 | Bunck MC Eliasson B Comer A | 2011 | Diabetes Obes Metab2011，13，4： | 1 |
| 9 | Acute and 2-week exposure to prednisolone impair different aspects of b-cell function in healthy men显示文摘 | van Raalte DH Nofrate V Bunck MC | | 0，，： | 1 |
| 10 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metfonnin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes care2009，32，5： | 1 |
| 11 | Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drugnaive patients with type 2 diabetes and mild hyperglyeaemia:a randomised eon- trolled trial显示文摘 | Foley JE Bunck MC MNler-Goede DL | 2011 | Diabetologia2011，54，8： | 1 |
| 12 | Long-term treatment of transsexuals with cross-sex hormones : extensive personal experience 显示文摘 | Gooren LJ Gihay E J Bunck MC | 2008 | J Clin En- doerinol Metab2008，93，1： | 1 |
| 13 | Incretin mimetics as a novel therapeutic option for hepatic steatosis显示文摘 | Tushuizen ME Bunck MC Pouwels P J | 2006 | Liver tnt2006，26，8： | 1 |
| 14 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin- treated type 2 diabetic patients: a randomized, controlled trial显示文摘 | Bunck MC Diamant M Comer A | 2009 | Diabetes Care2009，32，5： | 1 |
| 15 | One-year treatment with exenatide improves beta-cell function,compared with insulin glargine,in metformin-treated type 2 diabetic patients:a randomized,controlled trial显示文摘 | Bunck MC Diamant M Cornier A | | 0，，05： | 1 |
| 16 | Pancreatic fat content and beta - cell function in men with and without type 2 diabetes 显示文摘 | Tushuizen ME Bunck MC Pouwels PJ | 2007 | Diabetes Care2007，30，11： | 1 |
| 17 | Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia:a randomised controlled trial显示文摘 | Foley JE Bunck MC M(o)ller-Goede DL | | 0，，08： | 1 |
| 18 | Effects of exenatide on measures of p-cell function after 3 years in metfomlin-treated patients with type 2 diabetes显示文摘 | Bunck MC Comer A Eliasson B | 2011 | Diabetes Care2011，34，9： | 1 |
| 19 | One-year treatment with exenatide improves 显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
| 20 | One-year treatment with exenatide improves beta-cell funtion,compared with insulin glargine,in metformin-treated type 2 diabetes patients:a randomized,controled trail显示文摘 | Bunck MC Diamant M Corner A | 2009 | Diabetes Care2009，32，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员